Astrazeneca Drug For Chronic Allergic Fails Late Stage Trials
Despite the setback from the trial, AstraZeneca said it would continue to analyse the complete data set, which included 210 patients, and present its results at a future medical meeting., , astrazeneca, Asthama, drugs, trial run